Filing Details
- Accession Number:
- 0001144204-18-062799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-03 12:47:36
- Reporting Period:
- 2018-02-02
- Accepted Time:
- 2018-12-03 12:47:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1680048 | Mustang Bio Inc. | MBIO | Pharmaceutical Preparations (2834) | 473828760 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1760132 | Brian Achenbach | 2 Gansevoort Street 9Th Floor New York NY 10014 | Vp, Fin. & Corp. Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-02 | 55,000 | $0.00 | 55,000 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2018-11-16 | 1,000 | $4.31 | 56,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-19 | 1,000 | $4.25 | 57,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-11-20 | 500 | $3.87 | 57,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- 55,000 shares are restricted Common Stock which vest over various time periods.
- Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 16, 2018 was $4.15 to $4.3792, and the range of prices for the purchase transactions on November 19, 2018 was $4.15 to $4.35. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.